Annual report pursuant to Section 13 and 15(d)

Discontinued Operations, Disclosure

v3.7.0.1
Discontinued Operations, Disclosure
12 Months Ended
Dec. 31, 2015
Notes  
Discontinued Operations, Disclosure

7.  DISCONTINUED OPERATIONS

 

In efforts to streamline operations and expenses the Company elected to discontinue the Dr. Pave and Dr. Pave Worldwide entities during 2015.  The financial results of these events are represented in the discontinued operations included in the December 31, 2015 and 2014 financial statements.

 

The operating results of the discontinued operations of Dr. Pave and Dr. Pave Worldwide for the years ended December 31, 2015 and 2014 are summarized below:

 

 

2015

 

2014

Revenue

$

28,870

 

$

92,962

Expense

 

400,177

 

 

933,611

Net Loss, before taxes

 

(371,307)

 

 

(840,649)

Income tax benefit

 

--

 

 

--

Net Loss, net of tax

$

(371,307)

 

$

(840,649)

 

The balance sheet items for discontinued operations as of December 31, 2015 and 2014 are summarized below:

 

 

2015

 

2014

Cash and cash equivalents

$

12,350

 

$

25,044

Accounts receivable, net

 

--

 

 

2,785

Inventories

 

--

 

 

2,815

Other current assets

 

--

 

 

24,004

Total current assets

 

12,350

 

 

54,648

Fixed assets, net

 

--

 

 

107,457

Total assets

$

12,350

 

$

162,105

 

 

 

 

 

 

Payables and accrued liabilities

 

70,358

 

 

63,213

Short-term debt

 

229,980

 

 

389,980

Total liabilities

$

300,338

 

$

453,193

 

 

The Company’s borrowings included in discontinued operations as of December 31, 2015 and 2014 are as follows:

 

Revolving line of credit - The Company assumed a revolving line of credit through the acquisition of Dr. Pave in the amount of $229,980, and is secured by the assets of Dr. Pave, LLC a wholly owned subsidiary of the Company.  The total line of credit available is $250,000 with $20,020 unused as of December 31, 2015.  The balance on the line of credit bears interest at a rate of 12% per annum.  Interest is payable monthly on the first day of each month.  The outstanding principal balance as of July 1, 2015 shall become due and payable in sixty (60) equally amortized monthly installments of principal and interest due on the fifteenth day of each calendar month until paid in full.  As of December 31, 2015 no principal payments have been made, the Company is in default on the revolving line of credit.  The Company will work with the lenders to explore extension or conversion options.  There is no guarantee the lenders will accommodate our requests.

 

Interest on the revolving line of credit totaling $25,330 was outstanding at December 31, 2015.

 

Secured Notes Payable - The Company assumed secured notes payable through the acquisition of Dr. Pave in the amount of $160,000.  The principal amount and accrued interest in the amount of $14,361 was converted into the senior secured loan agreement as described below on June 30, 2015.